Korro Bio, Inc. (KRRO) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
KRRO Revenue Growth
KRRO Revenue Analysis (2017–2025)
As of May 8, 2026, Korro Bio, Inc. (KRRO) generated trailing twelve-month (TTM) revenue of $3.8 million, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q1 2026) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, KRRO's 5-year compound annual growth rate (CAGR) stands at -29.6%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $37.0 million in 2020.
When compared to Healthcare sector peers including BEAM (+108.0% YoY), CRSP (-88.9% YoY), and NTLA (+16.9% YoY), KRRO has underperformed the peer group in terms of revenue growth. Compare KRRO vs BEAM →
KRRO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| KRROCurrent | $4M | -100.0% | -29.6% | -1366.4% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% | |
 CRSP | $4M | -88.9% | +37.3% | -16191.4% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 PRME | $5M | -17.4% | -2.3% | -4498.1% |
KRRO Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.4M | +181.5% | $2.1M | 33.0% | $-87,342,000 | -1366.4% |
| 2024 | $2.3M | - | $2.3M | 100.0% | $-91,910,000 | -4047.1% |
| 2023 | $0 | - | $0 | - | $-84,534,000 | - |
| 2022 | $0 | -100.0% | $0 | - | $-58,998,000 | - |
| 2021 | $14.1M | -62.0% | $10.2M | 72.7% | $-84,031,000 | -597.3% |
| 2020 | $37.0M | +27.8% | $35.4M | 95.7% | $-27,550,000 | -74.5% |
| 2019 | $28.9M | - | $12.1M | 41.9% | $-20,675,000 | -71.4% |
| 2018 | $0 | - | $-654,000 | - | $-18,944,000 | - |
| 2017 | $0 | - | $-531,000 | - | $-16,306,000 | - |
See KRRO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KRRO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KRRO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKRRO — Frequently Asked Questions
Quick answers to the most common questions about buying KRRO stock.
Is KRRO's revenue growth accelerating or slowing?
KRRO revenue declined -100.0% year-over-year, contrasting with the 5-year CAGR of -29.6%. TTM revenue fell to $4M. This reverses the prior growth trend.
What is KRRO's long-term revenue growth rate?
Korro Bio, Inc.'s 5-year revenue CAGR of -29.6% reflects the variable expansion pattern. Current YoY growth of -100.0% is below this long-term average.
How is KRRO's revenue distributed by segment?
KRRO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.